The results showed that EGFR signaling could govern MEK/ERK pathway more strongly, however, the situation is not the same in BRAFV600E mutant lung cancer, which induce the receptor tyrosine kinases (RTKs) resistance problem (75). The gene discussed is EGFR; the disease is lung cancer.